Joshua L. Owen

Audie L. Murphy Memorial VA Hospital

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Brandon Worley

Northwestern University

Kishwer S. Nehal

Memorial Sloan Kettering Cancer Center

Murad Alam

Northwestern University

Nour Kibbi

Stanford University

Diana Bolotin

Cornell University

Todd V. Cartee

Penn State Milton S. Hershey Medical Center

Ian A. Maher

University of Minnesota

Naomi Lawrence

Cooper University Hospital

Vishnu Harikumar

Northwestern University

Joseph F. Sobanko

Hospital of the University of Pennsylvania

Cooperative Institutions

Northwestern University

The University of Texas Health Science Center at San Antonio

The University of Texas Southwestern Medical Center

American Academy of Dermatology

The University of Texas Health Science Center at Houston

Memorial Sloan Kettering Cancer Center

The University of Texas at San Antonio

University of California, San Francisco

Medical University of South Carolina

The University of Texas MD Anderson Cancer Center

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Response to Letter to the Editor for “‘stacked stitch’ for efficient closure of deep cutaneous defects”

JAAD International (2024)

Daniel C. Glade Aleksandar L. Krunic Joshua L. Owen

Closure (psychology)

10.1016/j.jdin.2023.12.007

Cite

Citations (0)

Treatment of Internal Nasal Valve Dysfunction After Mohs Surgery With a Novel Suspension Suture

Dermatologic Surgery (2024)

Joshua L. Owen Maryann England Gregory I. Kelts Jon M. Robitschek

Owen, Joshua L. MD, PhD; England, Maryann MS; Kelts, Gregory I. MD; Robitschek, Jon M. MD Author Information

Mohs surgery

10.1097/dss.0000000000004535

Cite

Citations (0)

Giant chondroid syringomas: Review of surgical challenges and treatment approaches, including excision, enucleation and Mohs micrographic surgery

Australasian Journal of Dermatology (2019)

Joshua L. Owen Sapna M. Amin Wenhua Liu Rakesh Chaudhari Joan Guitart

Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Surgical excision

10.1111/ajd.13204

Cite

Citations (0)

Aggressive subcutaneous trichoblastomas successfully treated with Mohs micrographic surgery

Australasian Journal of Dermatology (2018)

Joshua L. Owen Wenhua Liu Alexandru Croitoru Aleksandar L. Krunic

Mohs surgery

10.1111/ajd.12983

Cite

Citations (1)

Cutaneous manifestations of vemurafenib therapy for metastatic melanoma.

PubMed (2015)

Joshua L. Owen Isha E Lopez Seemal R. Desai

Vemurafenib, a BRAF inhibitor, is FDA-approved for the treatment of metastatic melanoma in patients who harbor the BRAF V600E mutation. By inhibiting BRAF, vemurafenib prevents the mitogen-activated protein kinase (MAPK) pathway from driving melanoma growth. Here we present a patient with paradoxical activation of the MAPK pathway by vemurafenib, ultimately resulting in deleterious cutaneous manifestations. An emphasis on close follow-up is warranted for new or changing lesions for patients on this medication and other BRAF inhibitors.

V600E

Source

Cite

Citations (2)

Comparative utility of appropriate use criteria versus clinical practice guidelines

Archives of Dermatological Research (2020)

Brandon Worley Rachel L. Kyllo Vishnu Harikumar Bianca Y. Kang Sarah A. Ibrahim

Clinical Practice

10.1007/s00403-020-02161-3

Cite

Citations (4)

Sebaceous carcinoma: controversies and their evidence for clinical practice

Archives of Dermatological Research (2019)

Nour Kibbi Brandon Worley Joshua L. Owen Ryan C. Kelm Christopher K. Bichakjian

Sebaceous carcinoma

10.1007/s00403-019-01971-4

Cite

Citations (26)

Widespread subacute cutaneous lupus erythematosus in a patient receiving checkpoint inhibitor immunotherapy with ipilimumab and nivolumab

Dermatology Online Journal (2019)

Cory Kosche Joshua L. Owen Jennifer Choi

Checkpoint inhibitor immunotherapy, including ipilimumab and nivolumab, is associated with numerous immune-related adverse events including dermatitis, pruritus, hepatitis, diarrhea, and hypophysitis. As the number of patients undergoing immunotherapy treatment increases, however, rare and unusual immune-related adverse events are observed. Many of these resemble known autoimmune phenomenon, such as subacute lupus erythematosus and myositis. Herein, we report a patient with metastatic serous ovarian carcinoma undergoing treatment with combination ipilimumab and nivolumab who developed subacute cutaneous lupus erythematosus (SCLE). Recent case reports have documented SCLE as a novel immune-related adverse event. In our case, she was able to successfully restart immunotherapy after a course of oral corticosteroids and maintenance oral hydroxychloroquine and topical corticosteroid therapy.

10.5070/d32510045821

Cite

Citations (20)

The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis

American Journal of Clinical Dermatology (2018)

Joshua L. Owen Paras P. Vakharia Jonathan I. Silverberg

Patch test

Immune Dysregulation

10.1007/s40257-017-0340-7

Cite

Citations (138)

Rare Presentation of a Rare Orthopedic Pathology: Erdheim Chester Disease

International Journal of Chronic Diseases & Therapy (2017)

Jason Samona Joshua L. Owen Sidney Martin

We describe a case report of an indolent form of Erdheim Chester Disease (ECD), in a patient in whom the disease has been present for approximately 14 years.Despite widespread sclerosis of long bones in the extremities, the patient has no complaints of peripheral bone pain.Although, the patient does have involvement AbstractIn 1930, William Chester and pathologist Jakob Erdheim discovered the pathology currently known as Erdheim Chester disease.There are only approximately 249 histologically confirmed patients to have been diagnosed with this disease as noted in the medical literature.We describe a case report of an indolent form of Erdheim Chester Disease (ECD), in a patient in whom the disease has been present for approximately 14 years.Despite widespread sclerosis of long bones in the extremities, the patient has no complaints of peripheral bone pain.Although, the patient does have involvement of the jaw with subsequent loss of multiple teeth secondary to the facial manifestations of the disease.This is also the first patient have the disease incidentally discovered after an ACL injury, and the first ECD patient to receive an ACL reconstruction.

Erdheim–Chester disease

Presentation (obstetrics)

10.19070/2572-7613-1700011

Cite

Citations (0)